Reassessing therapeutic antibodies for neglected and tropical diseases.

• Κύριοι συγγραφείς: Rob Hooft van Huijsduijnen (Συγγραφέας), Somei Kojima (Συγγραφέας), Dee Carter (Συγγραφέας), Hisafumi Okabe (Συγγραφέας), Akihide Sato (Συγγραφέας), Wataru Akahata (Συγγραφέας), Timothy N C Wells (Συγγραφέας), Kei Katsuno (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Public Library of Science (PLoS), 2020-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

In the past two decades there has been a significant expansion in the number of new therapeutic monoclonal antibodies (mAbs) that are approved by regulators. The discovery of these new medicines has been driven primarily by new approaches in inflammatory diseases and oncology, especially in immuno-o...